Concordance Between Device and Panel: Management Decision
| Panel Decision to Further Evaluate | |||
|---|---|---|---|
| Device Decision to Further Evaluate | No | Yes | All |
| Reference: panel consensus1 | |||
| No | 57/81 (70.4%) | 2/17 (11.8%) | 59/98 (60.2%) |
| Yes | 24/81 (29.6%) | 15/17 (88.2%) | 39/98 (39.8%) |
| Specificity (95% CI) | 0.70 (0.60–0.79) | ||
| Sensitivity (95% CI) | 0.88 (0.64–0.97) | ||
| NPV (95% CI) | 0.97 (0.88–0.99) | ||
| PPV (95% CI) | 0.39 (0.24–0.55) | ||
Notes: 1Panel consensus: only includes decision where all panel members agreed, regardless of the number of members in the panel. Panel consensus for management decision was available for 98 lesions only. Those without consensus were excluded from this analysis. 95% Confidence interval (CI) calculated accounting for the within-subject correlation using the Wilson method.
Abbreviations: NPV, negative predictive value; PPV, positive predictive value.